1
|
Thuringer D, Solary E, Garrido C. The Microvascular Gap Junction Channel: A Route to Deliver MicroRNAs for Neurological Disease Treatment. Front Mol Neurosci 2017; 10:246. [PMID: 28824376 PMCID: PMC5543088 DOI: 10.3389/fnmol.2017.00246] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2017] [Accepted: 07/24/2017] [Indexed: 12/25/2022] Open
Abstract
Brain microvascular endothelial cells (BMECs) separate the peripheral blood from the brain. These cells, which are surrounded by basal lamina, pericytes and glial cells, are highly interconnected through tight and gap junctions. Their permeability properties restrict the transfer of potentially useful therapeutic agents. In such a hermetic system, the gap junctional exchange of small molecules between cerebral endothelial and non-endothelial cells is crucial for maintaining tissue homeostasis. MicroRNA were shown to cross gap junction channels, thereby modulating gene expression and function of the recipient cell. It was also shown that, when altered, BMEC could be regenerated by endothelial cells derived from pluripotent stem cells. Here, we discuss the transfer of microRNA through gap junctions between BMEC, the regeneration of BMEC from induced pluripotent stem cells that could be engineered to express specific microRNA, and how such an innovative approach could benefit to the treatment of glioblastoma and other neurological diseases.
Collapse
Affiliation(s)
| | - Eric Solary
- INSERM U1170, Institut Gustave RoussyVillejuif, France
| | - Carmen Garrido
- INSERM U1231, Université de Bourgogne Franche ComtéDijon, France
| |
Collapse
|
2
|
Zhang J, Lv J, Zhang F, Che H, Liao Q, Huang W, Li S, Li Y. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma. J Neurooncol 2017; 133:553-559. [PMID: 28551850 DOI: 10.1007/s11060-017-2464-2] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2016] [Accepted: 05/05/2017] [Indexed: 12/15/2022]
Abstract
Accumulating evidence has supported the role of microRNAs in the initiation and development of malignant tumors. MicroRNA-211 (miR-211), which was reported to involve in diverse physiological activities in several cancers, was investigated for its expression in human glioma and adjacent normal brain tissues, as well as its correlation with patient prognosis. Glioma tissues and adjacent normal brain tissues were obtained from 82 patients who underwent surgical resection, and quantitative real-time polymerase chain reaction was performed to assess the expression level of miR-211. Here, we found that miR-211 was significantly decreased in glioma tissues compared with adjacent normal brain tissues (glioma, 3.52 ± 0.14 vs. normal, 4.96 ± 0.17, p < 0.001), and inversely associated with ascending WHO classification (grade III-IV, 3.16 ± 0.21 vs. grade I-II, 4.22 ± 0.26, p < 0.001). Then, the correlation of miR-211 with clinicopathological factors was investigated by Pearson's Chi square test, indicating that miR-211 might be a potential biomarker to predict the malignant status of glioma. Further, Kaplan-Meier curves with log-rank analysis were carried out to determine the relationship between miR-211 expression level and the overall survival rate of glioma patients. Our data showed that there was a close correlation between down-regulated miR-211 and shorter survival time in 82 patients (p = 0.026). Finally, the multivariate Cox regression analysis indicated that WHO grade (HR = 2.437, 95% CI 1.251-4.966, p = 0.007), KPS (HR = 2.215, 95% CI 1.168-4.259, p = 0.016), and miR-211 expression level (HR = 3.614, 95% CI 2.152-6.748, p < 0.001) were considered as independent risk factors for glioma prognosis. These results suggested that lower miR-211 expression might be a marker for poor prognosis of glioma patients.
Collapse
Affiliation(s)
- Jun Zhang
- Department of Neurosurgery, Dalang Hospital, Dongguan, 523770, Guangdong, China
| | - Jianguang Lv
- Department of Neurosurgery, Dalang Hospital, Dongguan, 523770, Guangdong, China
| | - Feng Zhang
- Department of Neurosurgery, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou, 511447, Guangdong, China
| | - Hongmin Che
- Department of Neurosurgery, The First Affiliated Hospital of Xi'an Medical University, Xi'an, 710077, Shaanxi, China
| | - Qiwei Liao
- Department of Neurosurgery, Dalang Hospital, Dongguan, 523770, Guangdong, China
| | - Wobin Huang
- Department of Neurosurgery, Dalang Hospital, Dongguan, 523770, Guangdong, China
| | - Shaopeng Li
- Department of Neurosurgery, People's Hospital, Dongguan, 523770, Guangdong, China.
| | - Yuqian Li
- Department of Neurosurgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710038, Shaanxi, China.
| |
Collapse
|